粪便标记物在炎症性肠病活动性评价中的应用进展  

Advance in Application of Fecal Markers for Evaluating Disease Activity in Inflammatory Bowel Disease

作　　者：孟丽丽[1] 吴战军[2] 

机构地区：[1]济南大学山东省医学科学院医学与生命科学学院,250062 [2]解放军第456医院消化内科,250062

出　　处：《胃肠病学》2015年第4期248-251,共4页Chinese Journal of Gastroenterology

摘　　要：炎症性肠病(IBD)是一组慢性非特异性肠道疾病,具有复发与缓解交替的病程特点,其疾病活动性的判断一直是临床医师关注的焦点。近年随着对IBD发病机制研究的不断深入,一些新的生物学标记物被发现。本文就近年已认可的和正在初步研究的IBD粪便标记物作一综述。Inflammatory bowel disease（ IBD）is a group of chronic nonspecific intestinal diseases characterized by a clinical relapsing-remitting behavior. The evaluation of disease activity is concerned by clinicians all the time. With the evolving in recognition of the pathogenesis of IBD,many novel biomarkers are emerging in recent years. This article reviewed advances in the accepted and ongoing research fecal markers of IBD.

关 键 词：炎症性肠病 粪便 生物学标记 疾病活动性 

分 类 号：R574.62[医药卫生—消化系统]